BE894376A - Preparation pharmaceutique - Google Patents

Preparation pharmaceutique

Info

Publication number
BE894376A
BE894376A BE0/208995A BE208995A BE894376A BE 894376 A BE894376 A BE 894376A BE 0/208995 A BE0/208995 A BE 0/208995A BE 208995 A BE208995 A BE 208995A BE 894376 A BE894376 A BE 894376A
Authority
BE
Belgium
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
BE0/208995A
Other languages
English (en)
French (fr)
Inventor
Ranchhordas Sheth Prabhakar
J L Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE894376A publication Critical patent/BE894376A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/208995A 1981-09-14 1982-09-13 Preparation pharmaceutique BE894376A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30149881A 1981-09-14 1981-09-14

Publications (1)

Publication Number Publication Date
BE894376A true BE894376A (fr) 1983-03-14

Family

ID=23163649

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208995A BE894376A (fr) 1981-09-14 1982-09-13 Preparation pharmaceutique

Country Status (11)

Country Link
JP (1) JPS5857315A (nl)
AT (1) AT385199B (nl)
BE (1) BE894376A (nl)
BG (1) BG60526B2 (nl)
CH (1) CH652025A5 (nl)
DE (1) DE3232873A1 (nl)
FR (1) FR2512676B1 (nl)
GB (1) GB2105590B (nl)
IT (1) IT1158048B (nl)
MX (1) MX9203173A (nl)
NL (1) NL190746C (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3659B (en) 1991-01-23 1996-01-25 Isis Pharma Gmbh Orally adminsterable drugs for the treatmentof central dopamine deficiency conditions

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
EP0198769A3 (en) * 1985-04-12 1987-09-02 Forest Laboratories, Inc. Floating sustained release therapeutic compositions
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
DE3642668A1 (de) * 1986-12-13 1988-06-23 Kamprad Joachim Schmerzmittel fuer menschen
DE3875716D1 (de) * 1987-12-31 1992-12-10 Asta Medica Ag Synergistische kombination von decarboxylasehemmern und l-dopa-pellets.
DE69017915T2 (de) * 1989-10-26 1995-07-27 Nippon Shinyaku Co Ltd Zubereitung für den magen.
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
AU8000494A (en) * 1993-10-29 1995-05-22 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
DE69423643T2 (de) * 1993-10-29 2000-09-07 R.P. Scherer Corp., Troy Schäumende gelatinkapselfüllung
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
AU2003282603A1 (en) * 2002-10-11 2004-05-04 Depomed Development Ltd Gastro-retentive levodopa delivery form
DE102004039196B4 (de) 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
DE102010023828A1 (de) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält
DE102014003744A1 (de) 2014-03-10 2015-09-10 Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) Produkt zur oralen Verabreichung bei Menschen oder Tieren mit mikrostrukturierten, gekapselten Inhaltsstoffen sowie Vorrichtung zum Herstellen eines derartigen Produkts und Verfahren zum Herstellen dieses Produkts
DE102022103658A1 (de) 2022-02-16 2023-08-17 Joachim Kamprad Arzneimittelzusammensetzung enthaltend L-Tryptophan (L-Try) und L-5-Hydroxytryptophan (5-HTP) sowie einen peripheren Abbauhemmer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409996A (de) * 1961-06-16 1966-03-31 Hoffmann La Roche Verfahren zur Herstellung von substituierten Hydrazinen
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
ZA713877B (en) * 1970-07-24 1972-03-29 Hoffmann La Roche Pharmaceutical composition
DE2305209A1 (de) * 1972-02-14 1973-08-23 Hoffmann La Roche Pharmazeutisches praeparat
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3659B (en) 1991-01-23 1996-01-25 Isis Pharma Gmbh Orally adminsterable drugs for the treatmentof central dopamine deficiency conditions

Also Published As

Publication number Publication date
CH652025A5 (de) 1985-10-31
FR2512676A1 (fr) 1983-03-18
GB2105590B (en) 1985-05-30
NL190746C (nl) 1994-08-01
FR2512676B1 (fr) 1987-01-23
MX9203173A (es) 1992-07-01
DE3232873A1 (de) 1983-03-31
NL8203343A (nl) 1983-04-05
JPS5857315A (ja) 1983-04-05
NL190746B (nl) 1994-03-01
AT385199B (de) 1988-02-25
ATA341582A (de) 1987-08-15
IT8223147A0 (it) 1982-09-07
BG60526B2 (bg) 1995-07-28
GB2105590A (en) 1983-03-30
IT1158048B (it) 1987-02-18
JPH0341447B2 (nl) 1991-06-24

Similar Documents

Publication Publication Date Title
MC1782A1 (fr) Preparation pharmaceutique
FI822191A0 (fi) Farmaceutisk blandning
DK68392A (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
DK237884D0 (da) Farmaceutisk praeparat
PT73686A (pt) Pharmaceutical formulation
DK481585D0 (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
BE894376A (fr) Preparation pharmaceutique
DK345682A (da) Pharmaceutiske expienser
FI832197A0 (fi) Farmaceutisk blandning
IT8248677A0 (it) Formulazioni farmaceutiche
DE3279806D1 (de) Corpuscules containing medicaments
FI810056L (fi) Farmaceutiska foereningar
DK58983D0 (da) Farmaceutisk praeparat
DK152219C (da) Azopigmentpraeparater
DK288686D0 (da) Farmaceutiske praeparater
FR2598617B1 (fr) Composition pharmaceutique
DK32182A (da) Flydende biocidt praeparat
FI831687A0 (fi) Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar
DK314283D0 (da) Farmaceutiske praeparater
FR2503161B1 (fr) Nouvelles fluoroprostacyclines, leur preparation et leur application pharmaceutique
MC1372A1 (fr) Preparations pharmaceutiques
MC1371A1 (fr) Preparations pharmaceutiques
NL193821B (nl) Farmaceutisch preparaat.
BE891013A (fr) Compositions pharmaceutique
IT8249072A0 (it) Composizioni farmaceutiche

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: F. *HOFFMANN-LA ROCHE A.G.

Effective date: 20020913